Per-Johan Jakobson

Has grant

Professor

Karolinska Institutet

Sweden

Research Interests

Explore related searches

Professors in Sweden Professors in Immunology Immunology professors in Sweden

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Per-Johan Jakobson is a Professor at Karolinska Institutet in Sweden. His research areas encompass inflammatory markers in ulcerative colitis, the analysis of oxylipins, and neuroprotective mechanisms involving NG2 glia. He has published extensively on therapeutic targets for various inflammatory conditions and the molecular dynamics in early rheumatoid arthritis. His recent work also explores innovative drug combinations and the therapeutic potential of mPGES-1 inhibition.

Recent Grants

Grant: Open

Determination of the role of prostaglandins in inflammatory diseases with cardiovascular comorbidities, new treatment opportunities and clinical implications

Open Date: 2024-01-01

Close Date: 2026-12-31

Grant: Close

Towards precision prevention and early therapy for RA

Open Date: 2021-10-01

Close Date: 2024-12-31

Grant: Close

Stromal-cancer cell interplay and immunomodulatory functions of prostaglandin E2 in the tumor microenvironment, a novel target for therapeutic intervention

Open Date:

Close Date:

Articles (12)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (27)

Francisco Schopfer

Associate Professor

University of Pittsburgh

UNITED STATES

Per-Johan Jakobson

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (12)

Technical recommendations for analyzing oxylipins by liquid chromatography–mass spectrometry

Interferon Regulator Factor 5: A Novel Inflammatory Marker and Promising Therapeutic Target in Ulcerative Colitis

High-mannose glycans from Schistosoma mansoni eggs are important for priming of Th2 responses via Dectin-2 and prostaglandin E2

In early rheumatoid arthritis, anticitrullinated peptide antibodies associate with low number of affected joints and rheumatoid factor associates with systemic inflammation

Urinary prostanoids are elevated by anti-TNF and anti-IL6 receptor disease-modifying antirheumatic drugs but are not predictive of response to treatment in early rheumatoid arthritis.

NG2 glia protect against prion neurotoxicity by inhibiting microglia-to-neuron prostaglandin E2 signaling

Microsomal prostaglandin E synthase-1 inhibition promotes shunting in arachidonic acid metabolism during inflammatory responses in vitro

High‐content screening of drug combinations of an <scp>mPGES</scp>‐1 inhibitor in multicellular tumor spheroids leads to mechanistic insights into neuroblastoma chemoresistance

Failure to apply standard limit-of-detection or limit-of-quantitation criteria to specialized pro-resolving mediator analysis incorrectly characterizes their presence in biological samples

Synthesis and Biological Evaluation of Novel Paracetamol-Triazole Conjugates

The anti-inflammatory and vasoprotective properties of mPGES-1 inhibition offer promising therapeutic potential.

Editorial: Insights in inflammation pharmacology: 2022.

Collaborators (27)

Francisco Schopfer

Cornelis Hokke

Anna Nicolaou

Martin Giera

Edward A Dennis

Gerhard Liebisch

Jianyang Liu

Irundika Dias

Lars Klareskog

Karin Larsson

Kristina Lend

Jürgen Stein

Julijana Ivanisevic

Charles N. Serhan

Ulrike Garscha

Louis Schmidt

Bruce Freeman

Ruth Andrew

Marina Korotkova

Makoto Arita

Ameer Taha

Oswald Quehenberger

Stacy Gelhaus Wendell

Andreas Weigert

Michael Murphy

Ivana Milic

Robert K Hofstetter

Make your next move.